|
Volumn 121, Issue 18, 2013, Pages 3543-3544
|
Blocking direct inhibitor bleeding
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTIDOTE;
ANTIVITAMIN K;
APIXABAN;
BENZAMIDINE;
BENZIMIDAZOLE;
BLOOD CLOTTING FACTOR;
BLOOD CLOTTING FACTOR 10A;
COLCHICINE;
DABIGATRAN;
DESIPRAMINE;
DIGOXIN;
HEMOSTATIC AGENT;
IDRAPARINUX;
MONOCLONAL ANTIBODY;
PROCOAGULANT;
PROTEINASE;
PYRIDINE;
RIVAROXABAN;
THROMBIN;
ANTITHROMBIN;
BENZIMIDAZOLE DERIVATIVE;
BETA ALANINE;
DRUG DERIVATIVE;
ANTIBODY COMBINING SITE;
BLEEDING;
BRAIN HEMORRHAGE;
BRAIN SURGERY;
DECOMPRESSION SURGERY;
DRUG ELIMINATION;
HEAVY CHAIN;
HUMAN;
HYDROGEN BOND;
LIGHT CHAIN;
MOLECULAR RECOGNITION;
NEUROSURGICAL DECOMPRESSION;
NOTE;
PATIENT SELECTION;
PRIORITY JOURNAL;
RISK;
SUBSTITUTION THERAPY;
SURFACE PLASMON RESONANCE;
THROMBOCYTE AGGREGATION;
X RAY CRYSTALLOGRAPHY;
ANIMAL;
CHEMISTRY;
DRUG ANTAGONISM;
MALE;
ANIMALS;
ANTIDOTES;
ANTITHROMBINS;
BENZIMIDAZOLES;
BETA-ALANINE;
MALE;
MLCS;
MLOWN;
|
EID: 84879723576
PISSN: 00064971
EISSN: 15280020
Source Type: Journal
DOI: 10.1182/blood-2013-03-489864 Document Type: Note |
Times cited : (8)
|
References (5)
|